Chemomab Therapeutics Ltd. Operating Lease Liability
Chemomab Therapeutics Ltd. (CMMB) had Operating Lease Liability of $324.00 thousand as of 2024-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-03-23
- 2024-12-31: Operating Lease, Liability $324.00K.
- 2023-12-31: Operating Lease, Liability $392.00K.
- 2022-12-31: Operating Lease, Liability $214.00K.
- 2021-12-31: Operating Lease, Liability $343.00K.
| Period end | Operating Lease, Liability |
|---|---|
| 2024-12-31 | $324.00K 20-F · filed 2026-03-23 |
| 2023-12-31 | $392.00K 20-F · filed 2026-03-23 |
| 2022-12-31 | $214.00K 20-F · filed 2024-03-28 |
| 2021-12-31 | $343.00K 20-F · filed 2024-03-28 |
| 2020-12-31 | $195.00K 10-K · filed 2021-03-09 |
| 2019-12-31 | $1.12M 10-K · filed 2020-03-17 |